Comparative Effectiveness Grants in Genomic and Personalized Medicine
As part of the American Recovery and Reinvestment Act of 2009, the National Cancer Institute recently funded seven research and research infrastructure Grand Opportunities.
Read more

The Cancer Genome Atlas Project to Map 20 Tumor Types - October 06, 2009
$175 million in Recovery Act funds supports second phase of The Cancer Genome Atlas (TCGA) project.
Read the story in the NCI Cancer Bulletin

President Barack Obama Addresses Recovery Act Investment in TCGA - September 30, 2009
Enabling The Cancer Genome Atlas to Map 20 Cancers
Read More | Webcast

Using ARRA Funds to Advance Cancer Research - September 22, 2009
Update on NCIs investment of Recovery Act funds and plans to provide continuing support for valuable research beyond the funding period.
Read the story in the NCI Cancer Bulletin

ACTNOW Opens the Gate for Timely, Novel Research - August 11, 2009
NCI announces a new program being supported by Recovery Act funding. The Accelerating Clinical Trials of Novel Oncologic Pathways (ACTNOW) program will advance targeted, personalized cancer treatment through 37 early-phase clinical trials of new cancer therapies.
Read the story in the NCI Cancer Bulletin

Recovery Act Boosts Informatics - May 5, 2009
Top federal health information technology officials are predicting that the Recovery Act will help push development and adoption of health IT and interconnectivity to dramatically new levels over the coming years.
Read the story in the NCI Cancer Bulletin

Recovery Act Impact - April 20, 2009
NCI Director John E. Niederhuber, M.D., discusses the impact of the Recovery Act on cancer research at the Annual Meeting of the American Association for Cancer Research.
Press Release | Webcast | Text